Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response. [electronic resource]

By: Contributor(s): Producer: 20100304Description: 723-30 p. digitalISSN:
  • 1527-7755
Subject(s): Online resources: In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.